'World-changing': BP targets tipped to tighten after landmark trial

BLOOD pressure targets will likely be reduced in the wake of a landmark trial showing that more aggressive treatment to get systolic BP down to <120 mmHg saves lives, specialists say.

The US National Institutes of Health–funded SPRINT trial found improved outcomes among over-50s patients at increased cardiovascular risk, but without diabetes, who were working towards a goal of <120 mmHg compared with those randomised to the standard target of <140 mmHg.

Results published today show the more intensively treated group had a 27% lower relative risk of death from any